Severe anemia in a patient with multiple sclerosis treated with natalizumab

Neurology. 2015 Feb 24;84(8):861. doi: 10.1212/01.wnl.0000461938.49936.52.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anemia / etiology*
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents